By Amy Norton HealthDay Reporter TUESDAY, Oct. 26, 2021 (HealthDay News) — High-dose radiation therapy may stall tumor growth in patients with advanced lung cancer who are not fully responding to drug therapies, a preliminary study suggests. The study involved patients whose lung cancer was considered “oligoprogressive.” That means the cancer had spread to other… Continue reading Targeted High-Dose Radiation Helps Fight Advanced Lung Cancer
SOURCES: Lindi Campbell, lung cancer advocate, Lexington, KY. Alice Berger, PhD, assistant professor, Human Biology Division, Fred Hutchinson Cancer Research Center. Ramaswamy Govindan, MD, professor of medicine (medical oncology); Anheuser Busch endowed chair in medical oncology, Washington University School of Medicine, St. Louis. Joy Feliciano, MD, associate professor of oncology, Johns Hopkins University School of… Continue reading Lung Cancer in Women Who Never Smoked
By Robert Preidt
FRIDAY, Aug. 20, 2021 (HealthDay News) — If you suffered a bout of COVID-19 and your lungs took a beating, new research has reassuring news: You will likely be spared long-term respiratory damage.
Scientists looked at COVID-19 survivors who had asymptomatic, moderate or severe COVID-19 infections… Continue reading No Lasting Lung Damage After Full Recovery From COVID-19
A therapy made from a Covid patient’s own blood is being trialled to treat lung scarring that’s left after hospitalisation. Doctors at Guy’s and St Thomas’ NHS Foundation Trust in London have begun a small trial using patients’ white blood cells. Filmed by Julius Peacock, edited by Rachael Buchanan Source link
By Alan Mozes HealthDay Reporter TUESDAY, June 1, 2021 (HealthDay News) — The health of your lungs may have a lot to do with the size of your bank account, a new, large study indicates. The finding follows a six-decade look at lung disease risk among more than 215,000 American children and adults. In general,… Continue reading Americans' Lung Health: The Poor Suffer Most
By Dennis Thompson HealthDay Reporter THURSDAY, May 20, 2021 (HealthDay News) — An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report. Atezolizumab reduced by 34% the risk of disease recurrence or death in a certain group of people with stage… Continue reading Immunotherapy Drug Fights Early-Stage Lung Cancer
When you hear the word “genes,” you might think about the ones you inherit from your parents. But while genes and lung cancer do have a tie, very few known genes can transfer a higher chance of lung cancer from parent to child.
“We don’t see those [people] very often at all, because most… Continue reading How Genes Affect Lung Cancer
SOURCES: Carly Ornstein, national director, lung cancer education, American Lung Association. Katie Brown, vice president, support and survivorship programs, LUNGevity Foundation. Bill McDermott, licensed clinical social worker; president, Association of Oncology Social Work. Paula Adamson, Greensboro, NC. Morhaf Al Achkar, MD, PhD, associate professor, family medicine, University of Washington, Seattle. Nichelle Stigger, member, LUNGevity board… Continue reading The Emotional Side of Lung Cancer